BindingDB logo
myBDB logout

12 articles for Dalian University of Technology

The following articles (labelled with PubMed ID or TBD) are for your review
PMIDArticle TitlePublishedDeposition
27671500 Wortmannilactones I-L, new NADH-fumarate reductase inhibitors, induced by adding suberoylanilide hydroxamic acid to the culture medium of Talaromyces wortmannii. 01-NOV-2016 20-JUL-2018
24095762 Design and application of a rigid quinazolone scaffold based on two-face Bima-helix mimicking. 04-NOV-2013 13-APR-2014
23659711 Study of binding thermodynamics in the optimization of BH3 mimetics. XX-OCT-2013 20-MAR-2014
23206987 3-Thiomorpholin-8-oxo-8H-acenaphtho [1,2-b] pyrrole-9-carbonitrile (S1) derivatives as pan-Bcl-2-inhibitors of Bcl-2, Bcl-xL and Mcl-1. 18-DEC-2012 24-SEP-2013
23314054 Fragment-based design, synthesis, and biological evaluation of N-substituted-5-(4-isopropylthiophenol)-2-hydroxynicotinamide derivatives as novel Mcl-1 inhibitors. 26-FEB-2013 24-SEP-2013
23220642 Novel soluble myeloid cell leukemia sequence 1 (Mcl-1) inhibitor (E,E)-2-(benzylaminocarbonyl)-3-styrylacrylonitrile (4g) developed using a fragment-based approach. 28-JAN-2013 24-SEP-2013
23167494 An anthraquinone scaffold for putative, two-face Bim BH3a-helix mimic. 13-DEC-2012 17-MAY-2013
22465091 A novel series of l-2-benzyloxycarbonylamino-8-(2-pyridyl)-disulfidyloctanoic acid derivatives as histone deacetylase inhibitors: design, synthesis and molecular modeling study. 30-APR-2012 07-FEB-2013
18639462 Nitrogen-containing flavonoid analogues as CDK1/cyclin B inhibitors: synthesis, SAR analysis, and biological activity. 11-AUG-2008 17-DEC-2012
22227214 Discovery of novel selective inhibitors for EGFR-T790M/L858R. 27-JAN-2012 22-JUL-2012
21684048 Probing the difference between BH3 groove of Mcl-1 and Bcl-2 protein: Implications for dual inhibitors design. 31-AUG-2011 23-MAR-2012
21235240 3-Thiomorpholin-8-oxo-8H-acenaphtho[1,2-b]pyrrole-9-carbonitrile (S1) based molecules as potent, dual inhibitors of B-cell lymphoma 2 (Bcl-2) and myeloid cell leukemia sequence 1 (Mcl-1): structure-based design and structure-activity relationship studies. 17-FEB-2011 23-AUG-2011